Choi Jung
Insider CIK 1650126 · ANNX Director · GBT See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANNX Annexon, Inc. | A Award deriv | 2026-06-11 | 2026-06-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2025-12-01 | 2025-12-03 | 33,000 | $4.19 | $138.3K | 33,000 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 13,814 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 9,060 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 3,125 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 28,628 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 38,739 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 36,225 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 40,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 35,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 32,098 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 1 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 1 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 42,400 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 26,454 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 15,460 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 25,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 226,672 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2022-09-29 | 2022-09-29 | 73,855 | — | $0 | 226,672 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-27 | 2022-09-29 | 2,674 | — | $0 | 1 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-27 | 2022-09-29 | 16,902 | — | $0 | 32,098 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-27 | 2022-09-29 | 2,275 | — | $0 | 36,225 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-27 | 2022-09-29 | 74,964 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-27 | 2022-09-29 | 2,674 | — | $0 | 1 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-27 | 2022-09-29 | 2,275 | $65.82 | $149.7K | 220,215 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-27 | 2022-09-29 | 16,902 | $16.40 | $277.2K | 217,940 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-27 | 2022-09-29 | 2,674 | $3.40 | $9.1K | 300,527 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-27 | 2022-09-29 | 2,674 | $3.40 | $9.1K | 297,853 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-27 | 2022-09-29 | 74,964 | $3.40 | $254.9K | 295,179 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-01 | 2022-09-06 | 2,763 | — | $0 | 13,814 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-01 | 2022-09-06 | 2,208 | — | $0 | 15,460 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-09-01 | 2022-09-06 | 1,861 | $68.15 | $126.8K | 201,038 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-01 | 2022-09-06 | 2,208 | — | $0 | 202,899 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-01 | 2022-09-06 | 2,763 | — | $0 | 200,691 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-08-01 | 2022-08-03 | 3,020 | — | $0 | 9,060 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-08-01 | 2022-08-03 | 3,125 | — | $0 | 3,125 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-08-01 | 2022-08-03 | 2,126 | $32.40 | $68.9K | 197,928 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-08-01 | 2022-08-03 | 6,145 | — | $0 | 200,054 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 17,668 | — | $0 | 17,668 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-03-01 | 2022-03-03 | 2,763 | — | $0 | 16,577 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 17,668 | — | $0 | 17,668 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 28,628 | — | $0 | 28,628 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-03-01 | 2022-03-03 | 2,763 | — | $0 | 192,330 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-03-01 | 2022-03-03 | 956 | $29.87 | $28.6K | 191,374 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,125 | — | $0 | 6,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 2,875 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,020 | — | $0 | 12,080 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-02-01 | 2022-02-03 | 9,020 | — | $0 | 192,907 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-02-01 | 2022-02-03 | 3,340 | $29.33 | $98.0K | 189,567 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-09-01 | 2021-09-03 | 2,762 | — | $0 | 19,340 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-09-01 | 2021-09-03 | 1,370 | $29.85 | $40.9K | 183,887 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-09-01 | 2021-09-03 | 2,762 | — | $0 | 185,257 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2021-08-31 | 2021-09-03 | 128 | $24.39 | $3.1K | 182,495 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 2,875 | — | $0 | 2,875 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 3,020 | — | $0 | 15,100 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 3,125 | — | $0 | 9,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 3,020 | — | $0 | 15,100 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 3,125 | — | $0 | 9,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 2,875 | — | $0 | 2,875 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-08-01 | 2021-08-03 | 3,743 | $27.33 | $102.3K | 182,367 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-08-01 | 2021-08-03 | 9,020 | — | $0 | 186,110 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-08-01 | 2021-09-24 | 9,020 | — | $0 | 186,110 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-08-01 | 2021-09-24 | 3,743 | $27.33 | $102.3K | 182,367 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-03-01 | 2021-03-03 | 38,739 | — | $0 | 38,739 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-03-01 | 2021-03-03 | 22,102 | — | $0 | 22,102 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2021-02-28 | 2021-03-03 | 140 | $36.21 | $5.1K | 177,090 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 4,063 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,020 | — | $0 | 18,120 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,125 | — | $0 | 12,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 2,875 | — | $0 | 5,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-02-01 | 2021-02-03 | 13,083 | — | $0 | 181,596 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-02-01 | 2021-02-03 | 4,646 | $49.49 | $229.9K | 176,950 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 3,125 | — | $0 | 15,625 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 4,062 | — | $0 | 4,063 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 2,875 | — | $0 | 8,625 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 3,020 | — | $0 | 21,140 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-08-01 | 2020-08-04 | 6,239 | $67.48 | $421.0K | 168,513 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-08-01 | 2020-08-04 | 13,082 | — | $0 | 174,752 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2020-07-31 | 2020-08-04 | 162 | $36.68 | $5.9K | 161,670 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-01 | 2020-06-03 | 42,400 | — | $0 | 42,400 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 24,160 | — | $0 | 24,160 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 38,500 | — | $0 | 38,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 2,875 | — | $0 | 11,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 3,125 | — | $0 | 18,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 4,063 | — | $0 | 8,125 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-02-01 | 2020-02-04 | 10,063 | — | $0 | 165,078 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-02-01 | 2020-02-04 | 3,570 | $65.26 | $233.0K | 161,508 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2020-01-31 | 2020-02-04 | 286 | $36.68 | $10.5K | 155,015 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-12-13 | 2019-12-17 | 5,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-12-13 | 2019-12-17 | 2,479 | $76.88 | $190.6K | 154,729 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-12-13 | 2019-12-17 | 5,000 | — | $0 | 157,208 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 4,062 | — | $0 | 12,188 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 3,125 | — | $0 | 21,875 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 2,875 | — | $0 | 14,375 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-08-01 | 2019-08-05 | 3,990 | $54.25 | $216.5K | 152,208 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-08-01 | 2019-08-05 | 10,062 | — | $0 | 156,198 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2019-07-31 | 2019-08-05 | 285 | $36.68 | $10.5K | 146,136 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-04-08 | 2019-04-10 | 2,000 | — | $0 | 5,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-04-08 | 2019-04-10 | 692 | $58.51 | $40.5K | 145,851 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-04-08 | 2019-04-10 | 2,000 | — | $0 | 146,543 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-02-01 | 2019-02-05 | 2,875 | — | $0 | 17,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-02-01 | 2019-02-05 | 4,063 | — | $0 | 16,250 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-02-01 | 2019-02-05 | 2,515 | $48.44 | $121.8K | 143,997 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-02-01 | 2019-02-05 | 6,938 | — | $0 | 146,512 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2019-01-31 | 2019-04-10 | 269 | $36.68 | $9.9K | 144,543 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-01 | 2018-08-03 | 2,875 | — | $0 | 20,125 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-01 | 2018-08-03 | 4,062 | — | $0 | 20,313 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-08-01 | 2018-08-03 | 3,440 | $43.15 | $148.4K | 139,574 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-08-01 | 2018-08-03 | 6,937 | — | $0 | 143,014 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-05-17 | 2018-05-21 | 601 | — | $0 | 2,675 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-05-17 | 2018-05-21 | 601 | — | $0 | 2,675 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-05-17 | 2018-05-21 | 198 | — | $0 | 74,964 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-05-17 | 2018-05-21 | 601 | $3.40 | $2.0K | 137,477 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-05-17 | 2018-05-21 | 198 | $3.40 | $673 | 136,275 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-05-17 | 2018-05-21 | 601 | $3.40 | $2.0K | 136,876 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-05-17 | 2018-05-21 | 1,600 | $48.25 | $77.2K | 136,077 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-05-17 | 2018-05-21 | 1,400 | $48.25 | $67.5K | 136,077 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-04-17 | 2018-04-19 | 601 | — | $0 | 3,276 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-04-17 | 2018-04-19 | 601 | — | $0 | 3,276 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-04-17 | 2018-04-19 | 198 | — | $0 | 75,162 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-04-17 | 2018-04-19 | 198 | $3.40 | $673 | 137,875 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-04-17 | 2018-04-19 | 601 | $3.40 | $2.0K | 138,476 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-04-17 | 2018-04-19 | 601 | $3.40 | $2.0K | 139,077 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-04-17 | 2018-04-19 | 1,400 | $45.50 | $63.7K | 137,677 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-04-17 | 2018-04-19 | 1,600 | $45.50 | $72.8K | 137,677 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-03-16 | 2018-03-20 | 198 | — | $0 | 75,360 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-03-16 | 2018-03-20 | 601 | — | $0 | 3,877 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-03-16 | 2018-03-20 | 601 | — | $0 | 3,877 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-03-16 | 2018-03-20 | 601 | $3.40 | $2.0K | 140,076 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-03-16 | 2018-03-20 | 601 | $3.40 | $2.0K | 140,677 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-03-16 | 2018-03-20 | 1,400 | $54.15 | $75.8K | 139,277 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-03-16 | 2018-03-20 | 198 | $3.40 | $673 | 139,475 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-03-16 | 2018-03-20 | 1,600 | $54.15 | $86.6K | 139,277 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-16 | 2018-02-21 | 198 | — | $0 | 75,558 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-16 | 2018-02-21 | 601 | — | $0 | 4,478 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-16 | 2018-02-21 | 601 | — | $0 | 4,478 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-02-16 | 2018-02-21 | 1,600 | $62.95 | $100.7K | 140,877 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-16 | 2018-02-21 | 601 | $3.40 | $2.0K | 141,676 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-16 | 2018-02-21 | 601 | $3.40 | $2.0K | 142,277 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-02-16 | 2018-02-21 | 1,400 | $62.95 | $88.1K | 140,877 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-16 | 2018-02-21 | 198 | $3.40 | $673 | 141,075 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-14 | 2018-02-16 | 2,000 | — | $0 | 7,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-02-14 | 2018-02-16 | 692 | $62.30 | $43.1K | 142,477 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-14 | 2018-02-16 | 2,000 | — | $0 | 143,169 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-02 | 23,000 | — | $0 | 23,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-01 | 2018-02-02 | 4,063 | — | $0 | 24,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-01 | 2018-02-02 | 4,063 | — | $0 | 141,463 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-02-01 | 2018-02-02 | 1,405 | $59.60 | $83.7K | 140,058 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-31 | 2018-02-02 | 2,000 | — | $0 | 9,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-31 | 2018-02-02 | 2,000 | — | $0 | 138,092 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-31 | 2018-02-02 | 692 | $57.90 | $40.1K | 137,400 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-24 | 2018-01-26 | 2,000 | — | $0 | 11,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-24 | 2018-01-26 | 2,000 | — | $0 | 136,778 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-24 | 2018-01-26 | 686 | $58.15 | $39.9K | 136,092 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-17 | 2018-01-18 | 601 | — | $0 | 5,079 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-17 | 2018-01-18 | 198 | — | $0 | 75,756 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-17 | 2018-01-18 | 601 | — | $0 | 5,079 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-17 | 2018-01-18 | 198 | $3.40 | $673 | 136,576 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-17 | 2018-01-18 | 601 | $3.40 | $2.0K | 137,778 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-01-17 | 2018-01-18 | 1,600 | $52.85 | $84.6K | 134,778 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-17 | 2018-01-18 | 601 | $3.40 | $2.0K | 137,177 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-01-17 | 2018-01-18 | 1,400 | $52.85 | $74.0K | 136,378 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-16 | 2018-01-18 | 2,000 | — | $0 | 13,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-16 | 2018-01-18 | 877 | $52.10 | $45.7K | 136,378 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-16 | 2018-01-18 | 2,000 | — | $0 | 137,255 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-12-18 | 2017-12-20 | 198 | — | $0 | 75,954 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-12-18 | 2017-12-20 | 601 | — | $0 | 5,680 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-12-18 | 2017-12-20 | 601 | — | $0 | 5,680 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-12-18 | 2017-12-20 | 601 | $3.40 | $2.0K | 136,054 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-12-18 | 2017-12-20 | 601 | $3.40 | $2.0K | 136,655 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-12-18 | 2017-12-20 | 1,400 | $36.55 | $51.2K | 135,255 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-12-18 | 2017-12-20 | 198 | $3.40 | $673 | 135,453 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-12-18 | 2017-12-20 | 1,600 | $36.55 | $58.5K | 135,255 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-11-17 | 2017-11-21 | 601 | — | $0 | 6,281 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-11-17 | 2017-11-21 | 601 | — | $0 | 6,281 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-11-17 | 2017-11-21 | 198 | — | $0 | 76,152 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-11-17 | 2017-11-21 | 601 | $3.40 | $2.0K | 137,654 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-11-17 | 2017-11-21 | 1,400 | $39.75 | $55.6K | 136,855 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-11-17 | 2017-11-21 | 1,600 | $39.75 | $63.6K | 136,855 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-11-17 | 2017-11-21 | 601 | $3.40 | $2.0K | 138,255 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-11-17 | 2017-11-21 | 198 | $3.40 | $673 | 137,053 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-10-17 | 2017-10-18 | 198 | — | $0 | 76,350 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-10-17 | 2017-10-18 | 601 | — | $0 | 6,882 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-10-17 | 2017-10-18 | 601 | — | $0 | 6,882 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-10-17 | 2017-10-18 | 198 | $3.40 | $673 | 138,653 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-10-17 | 2017-10-18 | 601 | $3.40 | $2.0K | 139,254 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-17 | 2017-10-18 | 1,600 | $32.65 | $52.2K | 138,455 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-17 | 2017-10-18 | 1,400 | $32.65 | $45.7K | 138,455 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-10-17 | 2017-10-18 | 601 | $3.40 | $2.0K | 139,855 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-09-29 | 2017-10-02 | 198 | — | $0 | 76,548 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-09-29 | 2017-10-02 | 601 | — | $0 | 7,483 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-09-29 | 2017-10-02 | 601 | — | $0 | 7,483 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-09-29 | 2017-10-02 | 198 | $3.40 | $673 | 140,253 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-09-29 | 2017-10-02 | 1,600 | $30.00 | $48.0K | 140,055 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-09-29 | 2017-10-02 | 601 | $3.40 | $2.0K | 141,455 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-09-29 | 2017-10-02 | 601 | $3.40 | $2.0K | 140,854 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-09-29 | 2017-10-02 | 1,400 | $30.00 | $42.0K | 140,055 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-08-31 | 2017-09-05 | 601 | — | $0 | 8,084 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-08-31 | 2017-09-05 | 601 | — | $0 | 8,084 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-08-31 | 2017-09-05 | 198 | — | $0 | 76,746 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-08-31 | 2017-09-05 | 1,400 | $30.00 | $42.0K | 141,655 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-08-31 | 2017-09-05 | 1,600 | $30.00 | $48.0K | 141,655 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-08-31 | 2017-09-05 | 198 | $3.40 | $673 | 141,853 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-08-31 | 2017-09-05 | 601 | $3.40 | $2.0K | 142,454 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-08-31 | 2017-09-05 | 601 | $3.40 | $2.0K | 143,055 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-08-11 | 2017-08-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-08-01 | 2017-08-03 | 4,062 | — | $0 | 28,438 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-08-01 | 2017-08-03 | 4,062 | — | $0 | 147,317 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2017-08-01 | 2017-08-03 | 1,527 | $25.10 | $38.3K | 145,790 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-07-21 | 2017-07-25 | 601 | — | $0 | 8,685 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-07-21 | 2017-07-25 | 198 | — | $0 | 76,944 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-07-21 | 2017-07-25 | 601 | — | $0 | 8,685 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-07-21 | 2017-07-25 | 601 | $3.40 | $2.0K | 144,054 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-07-21 | 2017-07-25 | 601 | $3.40 | $2.0K | 144,655 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-07-21 | 2017-07-25 | 1,400 | $30.00 | $42.0K | 143,255 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-07-21 | 2017-07-25 | 1,600 | $30.00 | $48.0K | 143,255 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-07-21 | 2017-07-25 | 198 | $3.40 | $673 | 143,453 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-01-17 | 2017-01-19 | 49,000 | — | $0 | 49,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-01-17 | 2017-01-19 | 32,500 | — | $0 | 32,500 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-09-29 | 2016-10-03 | 9,286 | — | $0 | 9,286 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-03-10 | 2016-03-14 | 9,286 | — | $0 | 9,286 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2016-02-01 | 2016-02-03 | 749 | $16.09 | $12.1K | 168,606 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2016-02-01 | 2016-03-14 | 749 | $16.09 | $12.1K | 143,606 | SEC↗ |
| GBT Global Blood Therapeutics, | P Buy | 2015-08-17 | 2016-01-07 | 25,000 | $20.00 | $500.0K | 167,857 | SEC↗ |
| GBT Global Blood Therapeutics, | P Buy | 2015-08-17 | 2016-03-14 | 25,000 | $20.00 | $500.0K | 25,000 | SEC↗ |